24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Cancer
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
17:40
From startup exits to psychedelic therapy: Eyal Gura’s new mission
11:59
The rise of deathbots: When grief meets artificial intelligence
11:21
“A profound threat”: Congress links China’s DeepSeek to espionage, AI theft, and surveillance infrastructure
10:59
The million-dollar draft: How Israeli players are breaking into the NBA—and cashing in
More stories
Buzz
Most popular
Daily
Weekly
1
“I don’t want to be the richest man in the cemetery” — Morris Kahn on giving it all away at 95
2
Layoffs loom as Intel’s new CEO moves to fix slow decision-making and chip production
3
From startup exits to psychedelic therapy: Eyal Gura’s new mission
4
The million-dollar draft: How Israeli players are breaking into the NBA—and cashing in
5
“Suffocating innovation”: Intel’s new CEO dismantles hierarchy
More news
Cancer
8 stories about Cancer
Gilead Builds on Kite Pharma Acquisition, Buys Second CAR-T Therapy Company
10.12.17
|
Lilach Baumer
California-based Cell Design Labs will be acquired in a deal valued at up to $567 million
Pharma Veteran Julian Adams takes Helm at Gamida Cell
21.11.17
|
Lilach Baumer
The Novartis-backed company is developing a universal bone marrow transplant solution for patients unable to find a donor
VBL Therapeutics Aims to Raise $18.75 Million in Public Offering
20.11.17
|
Lilach Baumer
The cancer treatment company announced an offering of 2.5 million shares last week
Pontifax Leads $9.5 Funding Round for Biopharmaceutical Company ArQule
19.11.17
|
CTech
Nasdaq-listed ArQule develops treatments for cancer and rare diseases
Generic Focus made Kite Pharma Founder Leave Teva
13.11.17
|
Dror Reich
Founder of cancer treatment company sold to Gilead Sciences for $12 billion, says Gilead wants “to crack the cancer market"
Cancer Treatment Company Negotiating $20-25 Million Capital Injection
29.10.17
|
Lilach Baumer
The potential investors condition the investment on delisting BioCanCell from the Tel Aviv Stock Exchange
Kite Pharma’s Cancer Drug Gets Regulatory Nod
19.10.17
|
Lilach Baumer
The cancer-treatment company, bought by Gilead Science in August for $11.9 billion, will sell one treatment course of the drug for $373,000
Kite Pharma Sale Triggers Scientist Quarrel
02.10.17
|
Zohar Shahar Levy
Zelig Eshhar who patented the company’s core technology is now being sued by his former PhD student and current pharma entrepreneur
Previous Articles